Literature DB >> 7264955

Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories.

A M Young, J H Woods.   

Abstract

Rhesus monkeys lever-pressed under a fixed-ratio 30 time-out 600 sec schedule of i.v. injection of codeine (0.32 mg/kg/injection) or, in a second group of monkeys, ketamine (1.0 mg/kg/injection). During single session substitutions, the maintenance drug was replaced with saline or doses of various other drugs. At appropriate doses, ketamine maintained responding when substituted for ketamine. Phencyclidine, dexoxadrol and dextrorphan maintained responding when substituted for ketamine but did not maintain responding when substituted for codeine. Cyclazocine and SKF-10,047 (N-allyl-normetazocine) did not maintain responding when substituted for either ketamine or codeine; ethylketazocine did not maintain responding when substituted for ketamine. For those drugs maintained under behavior, fixed-ratio response rate and the number of injection dose and then decreased at higher injection doses. Substituted drugs maintained maximum response rates at the following injection doses: codeine, 0.32 mg/kg; ketamine, 1.0 mg/kg; phencyclidine, 0.03 mg/kg, dexoxadrol, 0.32 mg/kg; and dextrorphan, 1.0 mg/kg. Under only the ketamine maintenance schedule, the rate of responding during the timeout component varied as a function of the substitution dose of ketamine, codeine, phencyclidine and dexoxadrol, with the dose that maintained maximal fixed-ratio rates also engendering the highest rates of timeout responding.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7264955

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  24 in total

Review 1.  Determinants of opioid abuse potential: Insights using intracranial self-stimulation.

Authors:  S Stevens Negus; Megan J Moerke
Journal:  Peptides       Date:  2018-11-01       Impact factor: 3.750

2.  Analysis of fixed-ratio behavior maintained by drug reinforcers.

Authors:  P Skjoldager; G Winger; J H Woods
Journal:  J Exp Anal Behav       Date:  1991-09       Impact factor: 2.468

3.  Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats.

Authors:  J A Suyama; M L Banks; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2018-09-19       Impact factor: 4.530

4.  Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists.

Authors:  Takato Hiranita; Maddalena Mereu; Paul L Soto; Gianluigi Tanda; Jonathan L Katz
Journal:  Neuropsychopharmacology       Date:  2012-11-28       Impact factor: 7.853

Review 5.  Animal models of substance abuse and addiction: implications for science, animal welfare, and society.

Authors:  Wendy J Lynch; Katherine L Nicholson; Mario E Dance; Richard W Morgan; Patricia L Foley
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

6.  Abuse liability of mitragynine assessed with a self-administration procedure in rats.

Authors:  Kai Yue; Theresa A Kopajtic; Jonathan L Katz
Journal:  Psychopharmacology (Berl)       Date:  2018-07-23       Impact factor: 4.530

7.  Pharmacological and non-pharmacological factors that regulate the acquisition of ketamine self-administration in rats.

Authors:  Marco Venniro; Anna Mutti; Cristiano Chiamulera
Journal:  Psychopharmacology (Berl)       Date:  2015-09-21       Impact factor: 4.530

8.  Dissociable effects of the noncompetitive NMDA receptor antagonists ketamine and MK-801 on intracranial self-stimulation in rats.

Authors:  Todd M Hillhouse; Joseph H Porter; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2014-02-13       Impact factor: 4.530

9.  The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users.

Authors:  Joshua A Lile; Thomas H Kelly; Lon R Hays
Journal:  Behav Pharmacol       Date:  2010-02       Impact factor: 2.293

10.  Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats.

Authors:  Takato Hiranita; Stephen J Kohut; Paul L Soto; Gianluigi Tanda; Theresa A Kopajtic; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2013-11-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.